Phase I study of camrelizumab in patients with advanced solid tumors

被引：0
|
作者：
Yuxiang Ma
Jiaxin Cao
Yang Zhang
Qianwen Liu
Wenfeng Fang
Yunpeng Yang
Yuanyuan Zhao
Qing Yang
Hongyun Zhao
Li Zhang
机构：
[1] Sun Yat-sen University Cancer Center,Department of Clinical Research
[2] State Key Laboratory of Oncology in South China,Department of Medical Oncology
[3] Collaborative Innovation Center for Cancer Medicine,undefined
[4] Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy,undefined
[5] Sun Yat-sen University Cancer Center,undefined
[6] State Key Laboratory of Oncology in South China,undefined
[7] Collaborative Innovation Center for Cancer Medicine,undefined
[8] Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy,undefined
[9] Jiangsu Hengrui Medicine Co. Ltd,undefined
来源：
Signal Transduction and Targeted Therapy | / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Phase I study of camrelizumab in patients with advanced solid tumors
    Ma, Yuxiang
    Cao, Jiaxin
    Zhang, Yang
    Liu, Qianwen
    Fang, Wenfeng
    Yang, Yunpeng
    Zhao, Yuanyuan
    Yang, Qing
    Zhao, Hongyun
    Zhang, Li
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [2] PHASE I STUDY OF AMATUXIMAB IN PATIENTS WITH ADVANCED SOLID TUMORS
    Fujisaka, Y.
    Kurata, T.
    Tanaka, K.
    Kudo, T.
    Okamoto, K.
    Tsurutani, J.
    Kaneda, H.
    Kitamura, C.
    Namiki, M.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2013, 24
  • [3] A phase I study of bortezomib and temozolomide in patients with advanced solid tumors
    Portnow, J.
    Frankel, P.
    Koehler, S.
    Twardowski, P.
    Shibata, S.
    Martel, C.
    Morgan, R.
    Cristea, M.
    Chow, W.
    Lim, D.
    Chung, V.
    Reckamp, K.
    Leong, L.
    Synold, T. W.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 505 - 514
  • [4] A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors
    Haddad, Tufia
    Qin, Rui
    Lupu, Ruth
    Satele, Daniel
    Eadens, Matthew
    Goetz, Matthew P.
    Erlichman, Charles
    Molina, Julian
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1221 - 1227
  • [5] A phase I study of oral ixabepilone in patients with advanced solid tumors
    Deeken, John F.
    Marshall, John L.
    Pishvaian, Michael J.
    Hwang, Jimmy
    Ahlers, Christoph M.
    Clemens, Pamela L.
    Parker, Susan M.
    Iacono, Lisa
    LoRusso, Patricia M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (05) : 1071 - 1078
  • [6] A phase i study of ixazomib and erlotinib in patients with advanced solid tumors
    Kato, Shumei
    Adashek, Jacob J.
    Subbiah, Vivek
    Fu, Siqing
    Sun, Mianen
    Nguyen, Ly
    Brown, Elsa J.
    Yap, Timothy A.
    Karp, Daniel D.
    Piha-Paul, Sarina A.
    Hong, David S.
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (01) : 99 - 105
  • [7] A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors
    Tufia Haddad
    Rui Qin
    Ruth Lupu
    Daniel Satele
    Matthew Eadens
    Matthew P. Goetz
    Charles Erlichman
    Julian Molina
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 1221 - 1227
  • [8] A phase I study of the ceramide nanoliposome in patients with advanced solid tumors
    Ciner, Aaron
    Gourdin, Theodore
    Davidson, Jeff
    Parette, Mylisa
    Walker, Susan J.
    Fox, Todd E.
    Jiang, Yixing
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (01) : 23 - 29
  • [9] Phase I study of docetaxel and ifosfamide in patients with advanced solid tumors
    Pronk, L
    Shrijvers, D
    LocciTonelli, D
    Verweij, J
    VanOosterom, AT
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 961 - 961
  • [10] A phase I study of resminostat in Japanese patients with advanced solid tumors
    Satoru Kitazono
    Yutaka Fujiwara
    Shinji Nakamichi
    Hidenori Mizugaki
    Hiroshi Nokihara
    Noboru Yamamoto
    Yasuhide Yamada
    Eri Inukai
    Osamu Nakamura
    Tomohide Tamura
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 1155 - 1161
12345